Echo Therapeutics, Inc.
Echo Therapeutics, Inc. (ECTE) is a publicly traded company in the Unknown sector. Across all available filings, 19 corporate insiders have executed 82 transactions totaling $491.0K, demonstrating a bullish sentiment with $491.0K in net insider flow. The most recent transaction on Mar 21, 2017 involved a transaction of 100,000 shares valued at $0.
ECTE Insider Activity Summary
Who Is Buying ECTE Stock?
No significant insider buying has been recorded for ECTE in the recent period.
Who Is Selling ECTE Stock?
No significant insider selling has been recorded for ECTE in the recent period.
Is Echo Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ECTE is bullish with an Insider Alignment Score of 100/100 and a net flow of $491.0K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ECTE Frequently Asked Questions
Understanding ECTE Insider Activity
Insider trading at Echo Therapeutics, Inc. (ECTE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 19 insiders are actively trading ECTE stock, having executed 82 transactions in the past 90 days. The most active insider is Life Sciences, Llc Platinum-montaur (Executive), who has made 4 transactions totaling $335.9K.
Related Tools
Track Echo Therapeutics, Inc. Insider Activity
Get notified when executives and directors at ECTE file new Form 4 transactions